Trials / Completed
CompletedNCT00005891
Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Fairview University Medical Center · Academic / Other
- Sex
- All
- Age
- 0 Years – 54 Years
- Healthy volunteers
- Not accepted
Summary
OBJECTIVES: I. Determine the effectiveness of moderate dose cyclophosphamide and total lymphoid radiotherapy in terms of improving the survival and reducing the morbidity following allogeneic bone marrow transplantation in patients with Fanconi's aplastic anemia.
Detailed description
PROTOCOL OUTLINE: Patients receive cyclophosphamide IV over 2 hours on day -6 through -3 and total lymphoid radiotherapy on day -1. Patients undergo allogeneic bone marrow transplantation on day 0. Patients are followed for at least 100 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cyclophosphamide | |
| PROCEDURE | Allogeneic Bone Marrow Transplantation |
Timeline
- Start date
- 2000-03-01
- First posted
- 2000-06-05
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00005891. Inclusion in this directory is not an endorsement.